Clindamycin in 5 Percent Dextrose (Sandoz Inc)


Welcome to the PulseAid listing for the Clindamycin in 5 Percent Dextrose drug offered from Sandoz Inc. This Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Clindamycin in 5 Percent Dextrose
SUBSTANCE NAME: CLINDAMYCIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-02-07
END MARKETING DATE: 0000-00-00


Clindamycin in 5 Percent Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionClindamycin in 5 Percent Dextrose from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/mL)
START MARKETING DATE: 2013-02-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3288_53ba38fd-a222-46f9-a105-91caeffde015
PRODUCT NDC: 0781-3288
APPLICATION NUMBER: ANDA201692

Other CLINDAMYCIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sandoz IncClindamycin in 5 Percent Dextrose